CONDENSED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 8,358,380	$ 4,281,904	$ 3,617,812	$ (11,644,456)	$ 12,640,284	$ (8,026,644)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(1,090,322)		(32,556)		(1,467,945)	(32,607)
Change in fair value of liabilities					(16,992,000)	(864,000)
Change in fair value of convertible note, net - related party	112,747				(252,364)	0
Transaction costs allocated to warrant liabilities					0	1,001,129
Initial classification of FPA liability					0	9,902,957
Change in fair value of FPA liability	(1,230,430)		(3,195,434)		4,669,749	(3,046,211)
Changes in operating assets and liabilities:
Prepaid expenses					245,739	(528,049)
Income Taxes Payable					280,433	0
Accounts payable and accrued expenses					(134,040)	330,563
Net cash used in operating activities					(1,010,144)	(1,262,862)
Cash Flows from Investing Activities:
Investment of cash in Trust Account					0	(690,000,000)
Cash withdrawn from Trust Account to pay franchise and income taxes					349,998	0
Net cash provided by (used in) investing activities					349,998	(690,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid					0	677,300,000
Proceeds from sale of Private Placements Warrants					0	14,700,000
Proceeds from convertible note					700,000	0
Proceeds from promissory note - related party					0	300,000
Repayment of promissory note - related party					0	(300,000)
Payment of offering costs					0	(624,388)
Net cash provided by financing activities					700,000	691,375,612
Net Change in Cash					39,854	112,750
Cash - Beginning of period		$ 6,563		$ 24,981	6,563	24,981	$ 24,981
Cash - End of period	$ 46,417		$ 137,731		46,417	137,731	$ 6,563
Non-Cash Investing and Financing Activities:
Offering costs included in accrued offering costs					0	17,000
Deferred underwriting fee payable					$ 0	$ 22,225,000